SCHEMBL28063990

SCHEMBL28063990

O=C(Nc1ccc(=O)[nH]c1)c1ccccc1-c1ccc(F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 4/20 0.67
SCN10A Q9Y5Y9 4/20 0.67
HTT P42858 2/20 0.52
TP53 P04637 1/20 0.52
CHRNB2 P17787 1/20 0.51
CHRNB4 P30926 1/20 0.51
CHRNA3 P32297 1/20 0.51
CHRNA4 P43681 1/20 0.51
LMNA P02545 2/20 0.50
MAPT P10636 2/20 0.48
SLC6A4 P31645 1/20 0.48
SLC6A3 Q01959 1/20 0.48
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
GAA P10253 2/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28063981 0.81 SCN8A (0.69) SCN8ASCN10APOLBMEN1KMT2A
SCHEMBL28064012 0.81 SCN8A (0.67) SCN8ASCN10AHTTTP53MAPT
SCHEMBL29970845 0.81 CHRNB2 (0.78) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL29201497 0.81 CHRNB2 (0.78) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL15561778 0.80 SCN8A (1.00) SCN8ASCN10AMEN1KMT2A
SCHEMBL28827912 0.73 P4HTM (0.70) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL6300626 0.73 HTT (0.72) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL974404 0.73 SLC6A3 (0.63) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL11186905 0.72 HTT (0.83) HTTTP53CHRNB2CHRNB4CHRNA3
SCHEMBL6053692 0.72 CYP2C9 (0.78) CHRNB2CHRNB4CHRNA3CHRNA4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105473554-A Fused piperidine amides as modulators of ion channels VERTEX PHARMA 2016-04-06 CN disclosed